Rosiglitazone Decreases C-Reactive Protein to a Greater Extent Relative to Glyburide and Metformin Over 4 Years Despite Greater Weight Gain: Observations from A Diabetes Outcome Progression Trial (ADOPT)

OBJECTIVE: C-reactive protein (CRP) is closely associated with obesity and cardiovascular disease in both diabetic and nondiabetic populations. In the short term, commonly prescribed antidiabetic agents have different effects on CRP; however, the long-term effects of those agents are unknown. RESEAR...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Kahn, Steven E., Haffner, Steven M., Viberti, Giancarlo, Herman, William H., Lachin, John M., Kravitz, Barbara G., Yu, Dahong, Paul, Gitanjali, Holman, Rury R., Zinman, Bernard
Format: Artigo
Langue:Inglês
Publié: American Diabetes Association 2010
Sujets:
Original Research
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC2797969/
https://ncbi.nlm.nih.gov/pubmed/19808911
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2337/dc09-1661
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires